PNC Financial Services Group’s Sangamo Therapeutics SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$18.9K Sell
35,000
-623
-2% -$337 ﹤0.01% 3599
2025
Q1
$23.4K Buy
35,623
+9,545
+37% +$6.26K ﹤0.01% 3472
2024
Q4
$26.6K Buy
26,078
+25,000
+2,319% +$25.5K ﹤0.01% 3399
2024
Q3
$934 Hold
1,078
﹤0.01% 4458
2024
Q2
$386 Sell
1,078
-124
-10% -$44 ﹤0.01% 4566
2024
Q1
$805 Hold
1,202
﹤0.01% 4416
2023
Q4
$653 Buy
1,202
+623
+108% +$338 ﹤0.01% 4369
2023
Q3
$347 Hold
579
﹤0.01% 4495
2023
Q2
$753 Sell
579
-428
-43% -$557 ﹤0.01% 4542
2023
Q1
$1.77K Sell
1,007
-301
-23% -$530 ﹤0.01% 4338
2022
Q4
$4.11K Sell
1,308
-2,571
-66% -$8.07K ﹤0.01% 4058
2022
Q3
$19K Buy
3,879
+744
+24% +$3.64K ﹤0.01% 3479
2022
Q2
$13K Sell
3,135
-828
-21% -$3.43K ﹤0.01% 3693
2022
Q1
$23K Buy
3,963
+3,508
+771% +$20.4K ﹤0.01% 3503
2021
Q4
$3K Hold
455
﹤0.01% 4090
2021
Q3
$4K Hold
455
﹤0.01% 4002
2021
Q2
$5K Hold
455
﹤0.01% 3894
2021
Q1
$6K Hold
455
﹤0.01% 3783
2020
Q4
$7K Hold
455
﹤0.01% 3655
2020
Q3
$4K Hold
455
﹤0.01% 3722
2020
Q2
$4K Sell
455
-1,500
-77% -$13.2K ﹤0.01% 3684
2020
Q1
$12K Buy
1,955
+1,500
+330% +$9.21K ﹤0.01% 3350
2019
Q4
$4K Hold
455
﹤0.01% 3698
2019
Q3
$4K Hold
455
﹤0.01% 3776
2019
Q2
$5K Hold
455
﹤0.01% 3747
2019
Q1
$4K Hold
455
﹤0.01% 3791
2018
Q4
$5K Hold
455
﹤0.01% 3721
2018
Q3
$8K Hold
455
﹤0.01% 3734
2018
Q2
$6K Hold
455
﹤0.01% 3808
2018
Q1
$9K Buy
+455
New +$9K ﹤0.01% 3762
2016
Q3
Sell
-432
Closed -$3K 4242
2016
Q2
$3K Sell
432
-17
-4% -$118 ﹤0.01% 4057
2016
Q1
$3K Buy
449
+16
+4% +$107 ﹤0.01% 4073
2015
Q4
$4K Hold
433
﹤0.01% 3958
2015
Q3
$2K Sell
433
-14,167
-97% -$65.4K ﹤0.01% 4306
2015
Q2
$162K Buy
14,600
+272
+2% +$3.02K ﹤0.01% 2365
2015
Q1
$226K Sell
14,328
-12,900
-47% -$203K ﹤0.01% 2147
2014
Q4
$413K Hold
27,228
﹤0.01% 1654
2014
Q3
$294K Buy
27,228
+27,000
+11,842% +$292K ﹤0.01% 1771
2014
Q2
$3K Buy
228
+30
+15% +$395 ﹤0.01% 3447
2014
Q1
$4K Sell
198
-40,302
-100% -$814K ﹤0.01% 3318
2013
Q4
$562K Hold
40,500
﹤0.01% 1307
2013
Q3
$424K Buy
+40,500
New +$424K ﹤0.01% 1445